ID DHE4_HUMAN Reviewed; 558 AA. AC P49448; B2R8G0; Q9UDQ4; DT 01-FEB-1996, integrated into UniProtKB/Swiss-Prot. DT 27-APR-2001, sequence version 2. DT 27-MAR-2024, entry version 191. DE RecName: Full=Glutamate dehydrogenase 2, mitochondrial; DE Short=GDH 2; DE EC=1.4.1.3; DE Flags: Precursor; GN Name=GLUD2; Synonyms=GLUDP1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC TISSUE=Retina; RX PubMed=8207021; DOI=10.1016/s0021-9258(19)89484-x; RA Shashidharan P., Michaelidis T.M., Robakis N.K., Kresovali A., RA Papamatheakis J., Plaitakis A.; RT "Novel human glutamate dehydrogenase expressed in neural and testicular RT tissues and encoded by an X-linked intronless gene."; RL J. Biol. Chem. 269:16971-16976(1994). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Testis; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15772651; DOI=10.1038/nature03440; RA Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D., RA Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L., RA Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C., RA Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A., RA Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P., RA Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D., RA Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D., RA Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L., RA Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P., RA Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G., RA Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J., RA Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D., RA Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L., RA Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z., RA Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S., RA Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S., RA Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O., RA Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H., RA Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T., RA Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L., RA Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R., RA Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y., RA Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K., RA Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J., RA Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L., RA Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S., RA Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A., RA Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., RA Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D., RA Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H., RA McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S., RA Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C., RA Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S., RA Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V., RA Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K., RA Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K., RA Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D., RA Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R., RA Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B., RA Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C., RA d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q., RA Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N., RA Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A., RA Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J., RA Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A., RA Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F., RA Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L., RA Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S., RA Rogers J., Bentley D.R.; RT "The DNA sequence of the human X chromosome."; RL Nature 434:325-337(2005). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Skin; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP ADP-RIBOSYLATION AT CYS-172. RX PubMed=16023112; DOI=10.1016/j.febslet.2005.06.041; RA Choi M.M., Huh J.W., Yang S.J., Cho E.H., Choi S.Y., Cho S.W.; RT "Identification of ADP-ribosylation site in human glutamate dehydrogenase RT isozymes."; RL FEBS Lett. 579:4125-4130(2005). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [7] RP TRANSIT PEPTIDE CLEAVAGE SITE, AND SUBCELLULAR LOCATION. RX PubMed=22709669; DOI=10.1016/j.neuint.2012.06.006; RA Kotzamani D., Plaitakis A.; RT "Alpha helical structures in the leader sequence of human GLUD2 glutamate RT dehydrogenase responsible for mitochondrial import."; RL Neurochem. Int. 61:463-469(2012). CC -!- FUNCTION: Important for recycling the chief excitatory CC neurotransmitter, glutamate, during neurotransmission. CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + L-glutamate + NAD(+) = 2-oxoglutarate + H(+) + NADH + CC NH4(+); Xref=Rhea:RHEA:15133, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:16810, ChEBI:CHEBI:28938, ChEBI:CHEBI:29985, CC ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.4.1.3; CC Evidence={ECO:0000255|PROSITE-ProRule:PRU10011}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + L-glutamate + NADP(+) = 2-oxoglutarate + H(+) + NADPH + CC NH4(+); Xref=Rhea:RHEA:11612, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:16810, ChEBI:CHEBI:28938, ChEBI:CHEBI:29985, CC ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.4.1.3; CC Evidence={ECO:0000255|PROSITE-ProRule:PRU10011}; CC -!- SUBUNIT: Homohexamer. {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Mitochondrion matrix CC {ECO:0000269|PubMed:22709669}. CC -!- TISSUE SPECIFICITY: Expressed in retina, testis and, at a lower level, CC brain. CC -!- PTM: Stoichiometry shows that ADP-ribosylation occurs in one subunit CC per catalytically active homohexamer. CC -!- SIMILARITY: Belongs to the Glu/Leu/Phe/Val dehydrogenases family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X66310; CAA46995.1; -; Genomic_DNA. DR EMBL; U08997; AAA20969.1; -; Genomic_DNA. DR EMBL; AK313356; BAG36157.1; -; mRNA. DR EMBL; AC006144; AAD05030.1; -; Genomic_DNA. DR EMBL; BC050732; AAH50732.1; -; mRNA. DR CCDS; CCDS14603.1; -. DR PIR; A53719; A53719. DR RefSeq; NP_036216.2; NM_012084.3. DR PDB; 6G2U; X-ray; 2.93 A; A/B/C/D/E/F=54-558. DR PDBsum; 6G2U; -. DR AlphaFoldDB; P49448; -. DR SMR; P49448; -. DR BioGRID; 109009; 32. DR IntAct; P49448; 13. DR MINT; P49448; -. DR STRING; 9606.ENSP00000327589; -. DR BindingDB; P49448; -. DR DrugBank; DB00142; Glutamic acid. DR DrugBank; DB00157; NADH. DR DrugCentral; P49448; -. DR GlyGen; P49448; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; P49448; -. DR PhosphoSitePlus; P49448; -. DR SwissPalm; P49448; -. DR BioMuta; GLUD2; -. DR DMDM; 13432152; -. DR REPRODUCTION-2DPAGE; IPI00027146; -. DR EPD; P49448; -. DR jPOST; P49448; -. DR MassIVE; P49448; -. DR MaxQB; P49448; -. DR PaxDb; 9606-ENSP00000327589; -. DR PeptideAtlas; P49448; -. DR ProteomicsDB; 56012; -. DR Pumba; P49448; -. DR Antibodypedia; 29957; 242 antibodies from 28 providers. DR DNASU; 2747; -. DR Ensembl; ENST00000328078.3; ENSP00000327589.1; ENSG00000182890.5. DR Ensembl; ENST00000673493.1; ENSP00000500546.1; ENSG00000288118.1. DR GeneID; 2747; -. DR KEGG; hsa:2747; -. DR MANE-Select; ENST00000328078.3; ENSP00000327589.1; NM_012084.4; NP_036216.2. DR UCSC; uc004eto.4; human. DR AGR; HGNC:4336; -. DR CTD; 2747; -. DR DisGeNET; 2747; -. DR GeneCards; GLUD2; -. DR HGNC; HGNC:4336; GLUD2. DR HPA; ENSG00000182890; Group enriched (liver, testis). DR MalaCards; GLUD2; -. DR MIM; 300144; gene. DR neXtProt; NX_P49448; -. DR OpenTargets; ENSG00000182890; -. DR PharmGKB; PA28738; -. DR VEuPathDB; HostDB:ENSG00000182890; -. DR eggNOG; KOG2250; Eukaryota. DR GeneTree; ENSGT00390000000854; -. DR HOGENOM; CLU_025763_1_0_1; -. DR InParanoid; P49448; -. DR OMA; DINALSC; -. DR OrthoDB; 45283at2759; -. DR PhylomeDB; P49448; -. DR TreeFam; TF313945; -. DR BioCyc; MetaCyc:HS00018-MONOMER; -. DR BRENDA; 1.4.1.3; 2681. DR PathwayCommons; P49448; -. DR Reactome; R-HSA-2151201; Transcriptional activation of mitochondrial biogenesis. DR Reactome; R-HSA-8964539; Glutamate and glutamine metabolism. DR SABIO-RK; P49448; -. DR SignaLink; P49448; -. DR SIGNOR; P49448; -. DR BioGRID-ORCS; 2747; 15 hits in 783 CRISPR screens. DR GeneWiki; GLUD2; -. DR GenomeRNAi; 2747; -. DR Pharos; P49448; Tbio. DR PRO; PR:P49448; -. DR Proteomes; UP000005640; Chromosome X. DR RNAct; P49448; Protein. DR Bgee; ENSG00000182890; Expressed in right testis and 100 other cell types or tissues. DR ExpressionAtlas; P49448; baseline and differential. DR GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell. DR GO; GO:0005739; C:mitochondrion; IDA:BHF-UCL. DR GO; GO:0043531; F:ADP binding; IDA:BHF-UCL. DR GO; GO:0004352; F:glutamate dehydrogenase (NAD+) activity; IDA:UniProtKB. DR GO; GO:0004354; F:glutamate dehydrogenase (NADP+) activity; IEA:RHEA. DR GO; GO:0004353; F:glutamate dehydrogenase [NAD(P)+] activity; IDA:BHF-UCL. DR GO; GO:0005525; F:GTP binding; IDA:BHF-UCL. DR GO; GO:0070728; F:leucine binding; IDA:BHF-UCL. DR GO; GO:0006537; P:glutamate biosynthetic process; IDA:BHF-UCL. DR GO; GO:0006538; P:glutamate catabolic process; IDA:BHF-UCL. DR GO; GO:0006536; P:glutamate metabolic process; IDA:UniProtKB. DR CDD; cd01076; NAD_bind_1_Glu_DH; 1. DR Gene3D; 1.10.287.140; -; 1. DR Gene3D; 3.40.50.10860; Leucine Dehydrogenase, chain A, domain 1; 1. DR Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1. DR InterPro; IPR046346; Aminoacid_DH-like_N_sf. DR InterPro; IPR006095; Glu/Leu/Phe/Val/Trp_DH. DR InterPro; IPR006096; Glu/Leu/Phe/Val/Trp_DH_C. DR InterPro; IPR006097; Glu/Leu/Phe/Val/Trp_DH_dimer. DR InterPro; IPR033524; Glu/Leu/Phe/Val_DH_AS. DR InterPro; IPR036291; NAD(P)-bd_dom_sf. DR InterPro; IPR033922; NAD_bind_Glu_DH. DR PANTHER; PTHR11606; GLUTAMATE DEHYDROGENASE; 1. DR PANTHER; PTHR11606:SF15; GLUTAMATE DEHYDROGENASE 2, MITOCHONDRIAL; 1. DR Pfam; PF00208; ELFV_dehydrog; 1. DR Pfam; PF02812; ELFV_dehydrog_N; 1. DR PRINTS; PR00082; GLFDHDRGNASE. DR SMART; SM00839; ELFV_dehydrog; 1. DR SUPFAM; SSF53223; Aminoacid dehydrogenase-like, N-terminal domain; 1. DR SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1. DR PROSITE; PS00074; GLFV_DEHYDROGENASE; 1. DR Genevisible; P49448; HS. PE 1: Evidence at protein level; KW 3D-structure; ADP-ribosylation; Mitochondrion; NADP; Oxidoreductase; KW Reference proteome; Transit peptide. FT TRANSIT 1..53 FT /note="Mitochondrion" FT /evidence="ECO:0000269|PubMed:22709669" FT CHAIN 54..558 FT /note="Glutamate dehydrogenase 2, mitochondrial" FT /id="PRO_0000007208" FT ACT_SITE 183 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10011" FT BINDING 84 FT /ligand="substrate" FT /evidence="ECO:0000250" FT MOD_RES 172 FT /note="ADP-ribosylcysteine" FT /evidence="ECO:0000269|PubMed:16023112" FT VARIANT 498 FT /note="S -> A (in dbSNP:rs9697983)" FT /id="VAR_048867" FT CONFLICT 286 FT /note="E -> Q (in Ref. 1; CAA46995/AAA20969)" FT /evidence="ECO:0000305" FT HELIX 66..87 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 95..109 FT /evidence="ECO:0007829|PDB:6G2U" FT STRAND 113..123 FT /evidence="ECO:0007829|PDB:6G2U" FT STRAND 129..138 FT /evidence="ECO:0007829|PDB:6G2U" FT STRAND 142..152 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 158..174 FT /evidence="ECO:0007829|PDB:6G2U" FT STRAND 180..186 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 190..192 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 195..211 FT /evidence="ECO:0007829|PDB:6G2U" FT TURN 217..219 FT /evidence="ECO:0007829|PDB:6G2U" FT STRAND 220..223 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 230..242 FT /evidence="ECO:0007829|PDB:6G2U" FT TURN 243..245 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 251..254 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 260..262 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 271..284 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 287..293 FT /evidence="ECO:0007829|PDB:6G2U" FT STRAND 297..299 FT /evidence="ECO:0007829|PDB:6G2U" FT STRAND 303..307 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 311..322 FT /evidence="ECO:0007829|PDB:6G2U" FT STRAND 326..331 FT /evidence="ECO:0007829|PDB:6G2U" FT STRAND 336..338 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 345..355 FT /evidence="ECO:0007829|PDB:6G2U" FT STRAND 364..367 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 371..373 FT /evidence="ECO:0007829|PDB:6G2U" FT STRAND 375..381 FT /evidence="ECO:0007829|PDB:6G2U" FT STRAND 383..386 FT /evidence="ECO:0007829|PDB:6G2U" FT TURN 390..392 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 393..395 FT /evidence="ECO:0007829|PDB:6G2U" FT STRAND 399..402 FT /evidence="ECO:0007829|PDB:6G2U" FT STRAND 405..407 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 411..419 FT /evidence="ECO:0007829|PDB:6G2U" FT STRAND 423..425 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 427..430 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 433..447 FT /evidence="ECO:0007829|PDB:6G2U" FT TURN 451..455 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 456..477 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 491..497 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 502..527 FT /evidence="ECO:0007829|PDB:6G2U" FT HELIX 534..551 FT /evidence="ECO:0007829|PDB:6G2U" SQ SEQUENCE 558 AA; 61434 MW; F222B1B2CB74A6EA CRC64; MYRYLAKALL PSRAGPAALG SAANHSAALL GRGRGQPAAA SQPGLALAAR RHYSELVADR EDDPNFFKMV EGFFDRGASI VEDKLVKDLR TQESEEQKRN RVRGILRIIK PCNHVLSLSF PIRRDDGSWE VIEGYRAQHS QHRTPCKGGI RYSTDVSVDE VKALASLMTY KCAVVDVPFG GAKAGVKINP KNYTENELEK ITRRFTMELA KKGFIGPGVD VPAPDMNTGE REMSWIADTY ASTIGHYDIN AHACVTGKPI SQGGIHGRIS ATGRGVFHGI ENFINEASYM SILGMTPGFR DKTFVVQGFG NVGLHSMRYL HRFGAKCIAV GESDGSIWNP DGIDPKELED FKLQHGSILG FPKAKPYEGS ILEVDCDILI PAATEKQLTK SNAPRVKAKI IAEGANGPTT PEADKIFLER NILVIPDLYL NAGGVTVSYF EWLKNLNHVS YGRLTFKYER DSNYHLLLSV QESLERKFGK HGGTIPIVPT AEFQDSISGA SEKDIVHSAL AYTMERSARQ IMHTAMKYNL GLDLRTAAYV NAIEKVFKVY SEAGVTFT //